S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
Log in
OTCMKTS:MMNFF

MedMen Enterprises Stock Forecast, Price & News

$0.19
+0.01 (+4.32 %)
(As of 01/15/2021 08:27 PM ET)
Add
Compare
Today's Range
$0.18
Now: $0.19
$0.20
50-Day Range
$0.12
MA: $0.15
$0.20
52-Week Range
$0.09
Now: $0.19
$0.65
Volume8.05 million shs
Average Volume6.82 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
MedMen Enterprises Inc., through its subsidiaries, operates as a cannabis company in the United States. The company cultivates, produces, distributes, and retails recreational and medicinal cannabis under the [statemade], LuxLyte, and MedMen Red brand names. It operates 25 retail stores in 6 states. MedMen Enterprises Inc. was founded in 2010 and is headquartered in Culver City, California.

MarketRank

Overall MarketRank

0.76 out of 5 stars

Analyst Opinion: 0.0Community Rank: 3.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:MMNFF
CUSIPN/A
CIKN/A
Phone855-292-8399
Employees1,000

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable
$0.19
+0.01 (+4.32 %)
(As of 01/15/2021 08:27 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MMNFF News and Ratings via Email

Sign-up to receive the latest news and ratings for MMNFF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











MedMen Enterprises (OTCMKTS:MMNFF) Frequently Asked Questions

How has MedMen Enterprises' stock been impacted by COVID-19?

MedMen Enterprises' stock was trading at $0.1539 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, MMNFF shares have increased by 25.4% and is now trading at $0.1930.
View which stocks have been most impacted by COVID-19
.

Is MedMen Enterprises a buy right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for MedMen Enterprises in the last twelve months. There are currently 1 sell rating and 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" MedMen Enterprises stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MMNFF, but not buy additional shares or sell existing shares.
View analyst ratings for MedMen Enterprises
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than MedMen Enterprises?

Wall Street analysts have given MedMen Enterprises a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but MedMen Enterprises wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting MedMen Enterprises?

MedMen Enterprises saw a increase in short interest during the month of December. As of December 31st, there was short interest totaling 3,814,200 shares, an increase of 28.3% from the December 15th total of 2,973,400 shares. Based on an average daily trading volume, of 12,632,600 shares, the short-interest ratio is currently 0.3 days.
View MedMen Enterprises' Short Interest
.

Who are some of MedMen Enterprises' key competitors?

Who are MedMen Enterprises' key executives?

MedMen Enterprises' management team includes the following people:
  • Mr. Adam Nathaniel Bierman, Co-Founder (Age 39, Pay $1.15M)
  • Mr. Michael Jay Lane, Chief Information Officer (Age 49, Pay $253.72k)
  • Mr. Zeeshan Hyder, Exec. Officer (Age 33, Pay $541.56k)
  • Mr. Thomas Jerome Lynch, Interim CEO & Chairman and Chief Restructuring Officer (Age 52)
  • Mr. Reece Fulgham, Interim Chief Financial Officer (Age 59)
  • Mr. Timothy Bossidy, Interim Chief Operating Officer (Age 32)
  • Ms. Stéphanie Van Hassel, VP of Investor Relations
  • Mr. Dan Edwards, Sr. VP of Legal Affairs
  • Christian Langbein, VP of Communications
  • Mr. Felix Popescu, Sr. VP of Strategic Planning

What is MedMen Enterprises' stock symbol?

MedMen Enterprises trades on the OTCMKTS under the ticker symbol "MMNFF."

How do I buy shares of MedMen Enterprises?

Shares of MMNFF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is MedMen Enterprises' stock price today?

One share of MMNFF stock can currently be purchased for approximately $0.19.

What is MedMen Enterprises' official website?

The official website for MedMen Enterprises is www.medmen.com.

How can I contact MedMen Enterprises?

The company can be reached via phone at 855-292-8399.

This page was last updated on 1/18/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.